A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/397 (2006.01) A61K 31/437 (2006.01) A61K 31/4468 (2006.01) A61P 3/04 (2006.01)
Patent
CA 2673290
The invention is directed to methods for treating and/or controlling obesity in a patient. The methods involve combination therapies using a microsomal triglyceride transfer protein (MTP) inhibitor (for example, AEGR-733 and implitapide) and a cholesterol absorption inhibitor (CAI) (for example, ezetimibe).
L'invention porte sur des procédés pour traiter et/ou contrôler l'obésité chez un patient. Les procédés mettent en jeu des thérapies de combinaison utilisant un inhibiteur de protéine de transfert de triglycéride microsomique (MTP) (par exemple, AEGR-733 et implitapide) et un inhibiteur de l'absorption du cholestérol (CAI) (par exemple, ézétimibe).
Aegerion Pharmaceuticals Inc.
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Methods for treating obesity with a combination comprising a... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for treating obesity with a combination comprising a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for treating obesity with a combination comprising a... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1818786